Viewing Study NCT02999633


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2026-03-01 @ 6:00 AM
Study NCT ID: NCT02999633
Status: TERMINATED
Last Update Posted: 2022-03-21
First Post: 2016-12-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None T-cell Type Acute Leukemia-Precursor View
None T-lymphoblastic Lymphoma/Leukaemia View
Keywords: